APO Research
Talk to an analyst

APO RESEARCH · REPORT

Liver Cirrhosis

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Liver Cirrhosis Market Analysis and Forecast 2026-2032

22 December 2025195 pages

Choose your research edition.

Industry ResearchLiver Cirrhosis Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Liver Cirrhosis Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Liver Cirrhosis Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Liver Cirrhosis Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Liver Cirrhosis Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Liver Cirrhosis market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Liver Cirrhosis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Liver Cirrhosis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Liver Cirrhosis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Liver Cirrhosis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Liver Cirrhosis include Johnson & Johnson, Merck, GlaxoSmithKline, Bristol-Myers Squibb, Intercept Pharmaceuticals, Instituto Grifols, Gwo Xi Stem Cell Applied Technology, Gilead Sciences and F Hoffman La-Roche, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Liver Cirrhosis, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Liver Cirrhosis, also provides the revenue of main regions and countries. Of the upcoming market potential for Liver Cirrhosis, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Liver Cirrhosis revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Liver Cirrhosis market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Liver Cirrhosis revenue, projected growth trends, production technology, application and end-user industry.

Liver Cirrhosis Segment by Company

Johnson & Johnson

Merck

GlaxoSmithKline

Bristol-Myers Squibb

Intercept Pharmaceuticals

Instituto Grifols

Gwo Xi Stem Cell Applied Technology

Gilead Sciences

F Hoffman La-Roche

Conatus Pharmaceuticals

Liver Cirrhosis Segment by Type

Cryptogenic Cirrhosis

Cardiac Cirrhosis

Atrophic Cirrhosis

Alcoholic Cirrhosis

Biliary Cirrhosis

Liver Cirrhosis Segment by Application

Hospitals

Specialty Clinics

Liver Cirrhosis Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Liver Cirrhosis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Liver Cirrhosis and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Liver Cirrhosis.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Liver Cirrhosis in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Liver Cirrhosis company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Liver Cirrhosis revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Liver Cirrhosis Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Cryptogenic Cirrhosis Major Player Table 3. Cardiac Cirrhosis Major Player Table 4. Atrophic Cirrhosis Major Player Table 5. Alcoholic Cirrhosis Major Player Table 6. Biliary Cirrhosis Major Player Table 7. Global Liver Cirrhosis Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Hospitals Major Player Table 9. Specialty Clinics Major Player Table 10. Liver Cirrhosis Industry Trends Table 11. Liver Cirrhosis Industry Drivers Table 12. Liver Cirrhosis Industry Opportunities and Challenges Table 13. Liver Cirrhosis Industry Restraints Table 14. Global Liver Cirrhosis Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Liver Cirrhosis Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Liver Cirrhosis Market Share by Region (2021-2026) Table 17. Global Liver Cirrhosis Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Liver Cirrhosis Market Share by Region (2027-2032) Table 19. Global Liver Cirrhosis Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Liver Cirrhosis Revenue Market Share by Players (2021-2026) Table 21. Global Liver Cirrhosis Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Liver Cirrhosis Key Players Headquarters & Area Served Table 23. Global Liver Cirrhosis Players, Product Type & Application Table 24. Global Liver Cirrhosis Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Liver Cirrhosis by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Liver Cirrhosis Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Liver Cirrhosis Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Liver Cirrhosis Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Liver Cirrhosis Revenue Market Share by Type (2021-2026) Table 31. Global Liver Cirrhosis Revenue Market Share by Type (2027-2032) Table 32. Global Liver Cirrhosis Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Liver Cirrhosis Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Liver Cirrhosis Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Liver Cirrhosis Revenue Market Share by Application (2021-2026) Table 36. Global Liver Cirrhosis Revenue Market Share by Application (2027-2032) Table 37. Johnson & Johnson Company Information Table 38. Johnson & Johnson Business Overview Table 39. Johnson & Johnson Liver Cirrhosis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Johnson & Johnson Liver Cirrhosis Product Portfolio Table 41. Johnson & Johnson Recent Development Table 42. Merck Company Information Table 43. Merck Business Overview Table 44. Merck Liver Cirrhosis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Merck Liver Cirrhosis Product Portfolio Table 46. Merck Recent Development Table 47. GlaxoSmithKline Company Information Table 48. GlaxoSmithKline Business Overview Table 49. GlaxoSmithKline Liver Cirrhosis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. GlaxoSmithKline Liver Cirrhosis Product Portfolio Table 51. GlaxoSmithKline Recent Development Table 52. Bristol-Myers Squibb Company Information Table 53. Bristol-Myers Squibb Business Overview Table 54. Bristol-Myers Squibb Liver Cirrhosis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Bristol-Myers Squibb Liver Cirrhosis Product Portfolio Table 56. Bristol-Myers Squibb Recent Development Table 57. Intercept Pharmaceuticals Company Information Table 58. Intercept Pharmaceuticals Business Overview Table 59. Intercept Pharmaceuticals Liver Cirrhosis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Intercept Pharmaceuticals Liver Cirrhosis Product Portfolio Table 61. Intercept Pharmaceuticals Recent Development Table 62. Instituto Grifols Company Information Table 63. Instituto Grifols Business Overview Table 64. Instituto Grifols Liver Cirrhosis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Instituto Grifols Liver Cirrhosis Product Portfolio Table 66. Instituto Grifols Recent Development Table 67. Gwo Xi Stem Cell Applied Technology Company Information Table 68. Gwo Xi Stem Cell Applied Technology Business Overview Table 69. Gwo Xi Stem Cell Applied Technology Liver Cirrhosis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Gwo Xi Stem Cell Applied Technology Liver Cirrhosis Product Portfolio Table 71. Gwo Xi Stem Cell Applied Technology Recent Development Table 72. Gilead Sciences Company Information Table 73. Gilead Sciences Business Overview Table 74. Gilead Sciences Liver Cirrhosis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Gilead Sciences Liver Cirrhosis Product Portfolio Table 76. Gilead Sciences Recent Development Table 77. F Hoffman La-Roche Company Information Table 78. F Hoffman La-Roche Business Overview Table 79. F Hoffman La-Roche Liver Cirrhosis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. F Hoffman La-Roche Liver Cirrhosis Product Portfolio Table 81. F Hoffman La-Roche Recent Development Table 82. Conatus Pharmaceuticals Company Information Table 83. Conatus Pharmaceuticals Business Overview Table 84. Conatus Pharmaceuticals Liver Cirrhosis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Conatus Pharmaceuticals Liver Cirrhosis Product Portfolio Table 86. Conatus Pharmaceuticals Recent Development Table 87. North America Liver Cirrhosis Revenue by Type (2021-2026) & (US$ Million) Table 88. North America Liver Cirrhosis Revenue by Type (2027-2032) & (US$ Million) Table 89. North America Liver Cirrhosis Revenue by Application (2021-2026) & (US$ Million) Table 90. North America Liver Cirrhosis Revenue by Application (2027-2032) & (US$ Million) Table 91. North America Liver Cirrhosis Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 92. North America Liver Cirrhosis Revenue by Country (2021-2026) & (US$ Million) Table 93. North America Liver Cirrhosis Revenue by Country (US$ Million) & (2027-2032) Table 94. Europe Liver Cirrhosis Revenue by Type (2021-2026) & (US$ Million) Table 95. Europe Liver Cirrhosis Revenue by Type (2027-2032) & (US$ Million) Table 96. Europe Liver Cirrhosis Revenue by Application (2021-2026) & (US$ Million) Table 97. Europe Liver Cirrhosis Revenue by Application (2027-2032) & (US$ Million) Table 98. Europe Liver Cirrhosis Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 99. Europe Liver Cirrhosis Revenue by Country (2021-2026) & (US$ Million) Table 100. Europe Liver Cirrhosis Revenue by Country (US$ Million) & (2027-2032) Table 101. China Liver Cirrhosis Revenue by Type (2021-2026) & (US$ Million) Table 102. China Liver Cirrhosis Revenue by Type (2027-2032) & (US$ Million) Table 103. China Liver Cirrhosis Revenue by Application (2021-2026) & (US$ Million) Table 104. China Liver Cirrhosis Revenue by Application (2027-2032) & (US$ Million) Table 105. Asia Liver Cirrhosis Revenue by Type (2021-2026) & (US$ Million) Table 106. Asia Liver Cirrhosis Revenue by Type (2027-2032) & (US$ Million) Table 107. Asia Liver Cirrhosis Revenue by Application (2021-2026) & (US$ Million) Table 108. Asia Liver Cirrhosis Revenue by Application (2027-2032) & (US$ Million) Table 109. Asia Liver Cirrhosis Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 110. Asia Liver Cirrhosis Revenue by Region (US$ Million) & (2021-2026) Table 111. Asia Liver Cirrhosis Revenue by Region (US$ Million) & (2027-2032) Table 112. SAMEA Liver Cirrhosis Revenue by Type (2021-2026) & (US$ Million) Table 113. SAMEA Liver Cirrhosis Revenue by Type (2027-2032) & (US$ Million) Table 114. SAMEA Liver Cirrhosis Revenue by Application (2021-2026) & (US$ Million) Table 115. SAMEA Liver Cirrhosis Revenue by Application (2027-2032) & (US$ Million) Table 116. SAMEA Liver Cirrhosis Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. SAMEA Liver Cirrhosis Revenue by Country (2021-2026) & (US$ Million) Table 118. SAMEA Liver Cirrhosis Revenue by Country (US$ Million) & (2027-2032) Table 119. Research Programs/Design for This Report Table 120. Authors List of This Report Table 121. Secondary Sources Table 122. Primary Sources List of Figures Figure 1. Liver Cirrhosis Image Figure 2. Global Liver Cirrhosis Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Liver Cirrhosis Market Size Share 2021 VS 2025 VS 2032 Figure 4. Cryptogenic Cirrhosis Image Figure 5. Cardiac Cirrhosis Image Figure 6. Atrophic Cirrhosis Image Figure 7. Alcoholic Cirrhosis Image Figure 8. Biliary Cirrhosis Image Figure 9. Global Liver Cirrhosis Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Liver Cirrhosis Market Size Share 2021 VS 2025 VS 2032 Figure 11. Hospitals Image Figure 12. Specialty Clinics Image Figure 13. Global Liver Cirrhosis Market Size (US$ Million) & (2021-2032) Figure 14. Global Liver Cirrhosis Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Liver Cirrhosis Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Liver Cirrhosis Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Liver Cirrhosis Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Liver Cirrhosis Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Liver Cirrhosis Revenue Market Share by Type (2021-2032) Figure 21. Global Liver Cirrhosis Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Liver Cirrhosis Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Liver Cirrhosis Revenue Market Share by Application (2021-2032) Figure 24. North America Liver Cirrhosis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Liver Cirrhosis Revenue Share by Type (2021-2032) Figure 26. North America Liver Cirrhosis Revenue Share by Application (2021-2032) Figure 27. North America Liver Cirrhosis Revenue Share by Country (2021-2032) Figure 28. United States Liver Cirrhosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Liver Cirrhosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Liver Cirrhosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Liver Cirrhosis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Liver Cirrhosis Revenue Share by Type (2021-2032) Figure 33. Europe Liver Cirrhosis Revenue Share by Application (2021-2032) Figure 34. Europe Liver Cirrhosis Revenue Share by Country (2021-2032) Figure 35. Germany Liver Cirrhosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Liver Cirrhosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Liver Cirrhosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Liver Cirrhosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Liver Cirrhosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Liver Cirrhosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Liver Cirrhosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Liver Cirrhosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Liver Cirrhosis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Liver Cirrhosis Revenue Share by Type (2021-2032) Figure 45. China Liver Cirrhosis Revenue Share by Application (2021-2032) Figure 46. Asia Liver Cirrhosis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Liver Cirrhosis Revenue Share by Type (2021-2032) Figure 48. Asia Liver Cirrhosis Revenue Share by Application (2021-2032) Figure 49. Asia Liver Cirrhosis Revenue Share by Region (2021-2032) Figure 50. Japan Liver Cirrhosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Liver Cirrhosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Liver Cirrhosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Liver Cirrhosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Liver Cirrhosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Liver Cirrhosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Liver Cirrhosis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Liver Cirrhosis Revenue Share by Type (2021-2032) Figure 58. SAMEA Liver Cirrhosis Revenue Share by Application (2021-2032) Figure 59. SAMEA Liver Cirrhosis Revenue Share by Country (2021-2032) Figure 60. Brazil Liver Cirrhosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Liver Cirrhosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Liver Cirrhosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Liver Cirrhosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Liver Cirrhosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Liver Cirrhosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Liver Cirrhosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Liver Cirrhosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Liver Cirrhosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Liver Cirrhosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Liver Cirrhosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Cryptogenic Cirrhosis
  • Cardiac Cirrhosis
  • Atrophic Cirrhosis
  • Alcoholic Cirrhosis
  • Biliary Cirrhosis
Applications
  • Hospitals
  • Specialty Clinics
Companies covered
  • Johnson & Johnson
  • Merck
  • GlaxoSmithKline
  • Bristol-Myers Squibb
  • Intercept Pharmaceuticals
  • Instituto Grifols
  • Gwo Xi Stem Cell Applied Technology
  • Gilead Sciences
  • F Hoffman La-Roche
  • Conatus Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Liver Cirrhosis Market by Type
  3. 1.2.1 Global Liver Cirrhosis Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Cryptogenic Cirrhosis
  5. 1.2.3 Cardiac Cirrhosis
  6. 1.2.4 Atrophic Cirrhosis
  7. 1.2.5 Alcoholic Cirrhosis
  8. 1.2.6 Biliary Cirrhosis
  9. 1.3 Liver Cirrhosis Market by Application
  10. 1.3.1 Global Liver Cirrhosis Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Hospitals
  12. 1.3.3 Specialty Clinics
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Liver Cirrhosis Market Dynamics
  1. 2.1 Liver Cirrhosis Industry Trends
  2. 2.2 Liver Cirrhosis Industry Drivers
  3. 2.3 Liver Cirrhosis Industry Opportunities and Challenges
  4. 2.4 Liver Cirrhosis Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Liver Cirrhosis Market Perspective (2021-2032)
  2. 3.2 Global Liver Cirrhosis Growth Trends by Region
  3. 3.2.1 Global Liver Cirrhosis Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Liver Cirrhosis Market Size by Region (2021-2026)
  5. 3.2.3 Global Liver Cirrhosis Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Liver Cirrhosis Revenue by Players
  2. 4.1.1 Global Liver Cirrhosis Revenue by Players (2021-2026)
  3. 4.1.2 Global Liver Cirrhosis Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Liver Cirrhosis Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Liver Cirrhosis Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Liver Cirrhosis Key Players Headquarters & Area Served
  7. 4.4 Global Liver Cirrhosis Players, Product Type & Application
  8. 4.5 Global Liver Cirrhosis Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Liver Cirrhosis Market CR5 and HHI
  11. 4.6.3 2025 Liver Cirrhosis Tier 1, Tier 2, and Tier 3
5 Liver Cirrhosis Market Size by Type
  1. 5.1 Global Liver Cirrhosis Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Liver Cirrhosis Revenue by Type (2021-2032)
  3. 5.3 Global Liver Cirrhosis Revenue Market Share by Type (2021-2032)
6 Liver Cirrhosis Market Size by Application
  1. 6.1 Global Liver Cirrhosis Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Liver Cirrhosis Revenue by Application (2021-2032)
  3. 6.3 Global Liver Cirrhosis Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Johnson & Johnson
  2. 7.1.1 Johnson & Johnson Company Information
  3. 7.1.2 Johnson & Johnson Business Overview
  4. 7.1.3 Johnson & Johnson Liver Cirrhosis Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Johnson & Johnson Liver Cirrhosis Product Portfolio
  6. 7.1.5 Johnson & Johnson Recent Developments
  7. 7.2 Merck
  8. 7.2.1 Merck Company Information
  9. 7.2.2 Merck Business Overview
  10. 7.2.3 Merck Liver Cirrhosis Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Merck Liver Cirrhosis Product Portfolio
  12. 7.2.5 Merck Recent Developments
  13. 7.3 GlaxoSmithKline
  14. 7.3.1 GlaxoSmithKline Company Information
  15. 7.3.2 GlaxoSmithKline Business Overview
  16. 7.3.3 GlaxoSmithKline Liver Cirrhosis Revenue and Gross Margin (2021-2026)
  17. 7.3.4 GlaxoSmithKline Liver Cirrhosis Product Portfolio
  18. 7.3.5 GlaxoSmithKline Recent Developments
  19. 7.4 Bristol-Myers Squibb
  20. 7.4.1 Bristol-Myers Squibb Company Information
  21. 7.4.2 Bristol-Myers Squibb Business Overview
  22. 7.4.3 Bristol-Myers Squibb Liver Cirrhosis Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Bristol-Myers Squibb Liver Cirrhosis Product Portfolio
  24. 7.4.5 Bristol-Myers Squibb Recent Developments
  25. 7.5 Intercept Pharmaceuticals
  26. 7.5.1 Intercept Pharmaceuticals Company Information
  27. 7.5.2 Intercept Pharmaceuticals Business Overview
  28. 7.5.3 Intercept Pharmaceuticals Liver Cirrhosis Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Intercept Pharmaceuticals Liver Cirrhosis Product Portfolio
  30. 7.5.5 Intercept Pharmaceuticals Recent Developments
  31. 7.6 Instituto Grifols
  32. 7.6.1 Instituto Grifols Company Information
  33. 7.6.2 Instituto Grifols Business Overview
  34. 7.6.3 Instituto Grifols Liver Cirrhosis Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Instituto Grifols Liver Cirrhosis Product Portfolio
  36. 7.6.5 Instituto Grifols Recent Developments
  37. 7.7 Gwo Xi Stem Cell Applied Technology
  38. 7.7.1 Gwo Xi Stem Cell Applied Technology Company Information
  39. 7.7.2 Gwo Xi Stem Cell Applied Technology Business Overview
  40. 7.7.3 Gwo Xi Stem Cell Applied Technology Liver Cirrhosis Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Gwo Xi Stem Cell Applied Technology Liver Cirrhosis Product Portfolio
  42. 7.7.5 Gwo Xi Stem Cell Applied Technology Recent Developments
  43. 7.8 Gilead Sciences
  44. 7.8.1 Gilead Sciences Company Information
  45. 7.8.2 Gilead Sciences Business Overview
  46. 7.8.3 Gilead Sciences Liver Cirrhosis Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Gilead Sciences Liver Cirrhosis Product Portfolio
  48. 7.8.5 Gilead Sciences Recent Developments
  49. 7.9 F Hoffman La-Roche
  50. 7.9.1 F Hoffman La-Roche Company Information
  51. 7.9.2 F Hoffman La-Roche Business Overview
  52. 7.9.3 F Hoffman La-Roche Liver Cirrhosis Revenue and Gross Margin (2021-2026)
  53. 7.9.4 F Hoffman La-Roche Liver Cirrhosis Product Portfolio
  54. 7.9.5 F Hoffman La-Roche Recent Developments
  55. 7.10 Conatus Pharmaceuticals
  56. 7.10.1 Conatus Pharmaceuticals Company Information
  57. 7.10.2 Conatus Pharmaceuticals Business Overview
  58. 7.10.3 Conatus Pharmaceuticals Liver Cirrhosis Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Conatus Pharmaceuticals Liver Cirrhosis Product Portfolio
  60. 7.10.5 Conatus Pharmaceuticals Recent Developments
8 North America
  1. 8.1 North America Liver Cirrhosis Revenue (2021-2032)
  2. 8.2 North America Liver Cirrhosis Revenue by Type (2021-2032)
  3. 8.2.1 North America Liver Cirrhosis Revenue by Type (2021-2026)
  4. 8.2.2 North America Liver Cirrhosis Revenue by Type (2027-2032)
  5. 8.3 North America Liver Cirrhosis Revenue Share by Type (2021-2032)
  6. 8.4 North America Liver Cirrhosis Revenue by Application (2021-2032)
  7. 8.4.1 North America Liver Cirrhosis Revenue by Application (2021-2026)
  8. 8.4.2 North America Liver Cirrhosis Revenue by Application (2027-2032)
  9. 8.5 North America Liver Cirrhosis Revenue Share by Application (2021-2032)
  10. 8.6 North America Liver Cirrhosis Revenue by Country
  11. 8.6.1 North America Liver Cirrhosis Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Liver Cirrhosis Revenue by Country (2021-2026)
  13. 8.6.3 North America Liver Cirrhosis Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Liver Cirrhosis Revenue (2021-2032)
  2. 9.2 Europe Liver Cirrhosis Revenue by Type (2021-2032)
  3. 9.2.1 Europe Liver Cirrhosis Revenue by Type (2021-2026)
  4. 9.2.2 Europe Liver Cirrhosis Revenue by Type (2027-2032)
  5. 9.3 Europe Liver Cirrhosis Revenue Share by Type (2021-2032)
  6. 9.4 Europe Liver Cirrhosis Revenue by Application (2021-2032)
  7. 9.4.1 Europe Liver Cirrhosis Revenue by Application (2021-2026)
  8. 9.4.2 Europe Liver Cirrhosis Revenue by Application (2027-2032)
  9. 9.5 Europe Liver Cirrhosis Revenue Share by Application (2021-2032)
  10. 9.6 Europe Liver Cirrhosis Revenue by Country
  11. 9.6.1 Europe Liver Cirrhosis Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Liver Cirrhosis Revenue by Country (2021-2026)
  13. 9.6.3 Europe Liver Cirrhosis Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Liver Cirrhosis Revenue (2021-2032)
  2. 10.2 China Liver Cirrhosis Revenue by Type (2021-2032)
  3. 10.2.1 China Liver Cirrhosis Revenue by Type (2021-2026)
  4. 10.2.2 China Liver Cirrhosis Revenue by Type (2027-2032)
  5. 10.3 China Liver Cirrhosis Revenue Share by Type (2021-2032)
  6. 10.4 China Liver Cirrhosis Revenue by Application (2021-2032)
  7. 10.4.1 China Liver Cirrhosis Revenue by Application (2021-2026)
  8. 10.4.2 China Liver Cirrhosis Revenue by Application (2027-2032)
  9. 10.5 China Liver Cirrhosis Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Liver Cirrhosis Revenue (2021-2032)
  2. 11.2 Asia Liver Cirrhosis Revenue by Type (2021-2032)
  3. 11.2.1 Asia Liver Cirrhosis Revenue by Type (2021-2026)
  4. 11.2.2 Asia Liver Cirrhosis Revenue by Type (2027-2032)
  5. 11.3 Asia Liver Cirrhosis Revenue Share by Type (2021-2032)
  6. 11.4 Asia Liver Cirrhosis Revenue by Application (2021-2032)
  7. 11.4.1 Asia Liver Cirrhosis Revenue by Application (2021-2026)
  8. 11.4.2 Asia Liver Cirrhosis Revenue by Application (2027-2032)
  9. 11.5 Asia Liver Cirrhosis Revenue Share by Application (2021-2032)
  10. 11.6 Asia Liver Cirrhosis Revenue by Country
  11. 11.6.1 Asia Liver Cirrhosis Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Liver Cirrhosis Revenue by Country (2021-2026)
  13. 11.6.3 Asia Liver Cirrhosis Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Liver Cirrhosis Revenue (2021-2032)
  2. 12.2 SAMEA Liver Cirrhosis Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Liver Cirrhosis Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Liver Cirrhosis Revenue by Type (2027-2032)
  5. 12.3 SAMEA Liver Cirrhosis Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Liver Cirrhosis Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Liver Cirrhosis Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Liver Cirrhosis Revenue by Application (2027-2032)
  9. 12.5 SAMEA Liver Cirrhosis Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Liver Cirrhosis Revenue by Country
  11. 12.6.1 SAMEA Liver Cirrhosis Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Liver Cirrhosis Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Liver Cirrhosis Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst